Terumo Neuro (formerly MicroVention) announced that it launched its Sofia 88 neurovascular support catheter in the U.S.

Terumo Neuro (formerly MicroVention) has launched the SOFIA 88 Neurovascular Support Catheter commercially in the US, making a new addition to its stroke portfolio. The large-bore catheter is ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced the commercial availability of the Sofia 88 ...

Terumo Neuro (formerly MicroVention) has launched the SOFIA 88 Neurovascular Support Catheter commercially in the US, making ...

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance and Innovation – The New SOFIA™ 88 Catheter Offers Reliable Trackability, Proximal Stability and ...

At the same time, an IV was also started in the patient's left arm, near the wound, but was later capped when a peripherally inserted central catheter (PICC) was placed in the right arm.

The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4%, reaching US$690.23 billion in 2025 and an impressive US$1,034.78 billion ...

analysis to analyze intracardiac electrograms and predict AF termination sites during catheter ablation. An additional 37 patients with persistent AF were used to prospectively validate the model.

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance and Innovation – The New SOFIA™ 88 Catheter Offers Reliable Trackability, Proximal Stability and ...